The different kinetic behavior of two potential photosensitizers for PDT

Journal of Photochemistry and Photobiology A: Chemistry

Volumn 299, Issue , 2015, Pages 38-43

  Barbero, Nadia ^a   Visentin, Sonja ^a   Viscardi, Guido ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bovine serum albumin; Fluorescence kinetics; Photodynamic therapy; Protoporphyrin; Squaraine

Indexed keywords

EID: 84910645247     PISSN: 10106030     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotochem.2014.11.002     Document Type: Article

References (41)

1. (a) K. Lang, J. Mosinger, D.M. Wagnerová, Photophysical properties of porphyrinoid sensitizers non-covalently bound to host molecules; models for photodynamic therapy, Coord. Chem. Rev. 248 (2004) 321-350;
2. (b) J. Moan, Q. Peng, An outline of the hundred-year history of PDT, Anticancer Res. 23 (2003) 3591-3600.
3. D. Bechet, P. Couleaud, C. Frochot, M.-L. Viriot, F. Guillemin, M. Barberi-Heyob, Nanoparticles as vehicles for delivery of photodynamic therapy agents, Trends Biotechnol. 26 (2008) 612-621.
4. (a) T. Peters, Serum albumin, Adv. Protein Chem. 37 (1985) 161-245;
5. (b) D.C. Carter, J.X. Ho, Structure of serum albumin, Adv. Protein Chem. 45 (1994) 153-203;
6. (c) N. Barbero, E. Barni, C. Barolo, P. Quagliotto, G. Viscardi, L. Napione, S. Pavan, F. Bussolino, A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence, Dyes Pigm. 80 (2009) 307-313.
7. T. Kosa, T. Maruyama, M. Otagiri, Species differences of serum albumins: I. Drug binding sites, Pharm. Res. 14 (1997) 1607-1612.
8. (a) U. Kragh-Hansen, Molecular aspects of ligand binding to serum albumin, Pharmacol. Rev. 33 (1981) 17-53;
9. (b) A.A. Rhodesa, B.L. Swartza, E.R. Hoslera, D.L. Snydera, K.M. Beniteza, B.S. Chohanb, S. Basu, Static quenching of tryptophan fluorescence in proteins by a dioxomolybdenum(VI) thiolate complex, J. Photochem. Photobiol. A: Chem. 293 (2014) 81-87;
10. (c) X. Yu, Z. Liao, B. Jiang, L. Zheng, X. Li, Study on the interaction between carbonyl-fused N-confused porphyrin and bovine serum albumin by spectroscopic techniques, Spectrochim. Acta Part A 133 (2014) 372-377;
11. (d) S. Chinnathambi, D. Velmurugan, N. Hanagata, P.R. Aruna, S. Ganesan, Investigations on the interactions of 5-fluorouracil with bovine serum albumin: optical spectroscopic and molecular modeling studies, J. Lumin. 151 (2014) 1-10.
12. (a) K. Szacilowski, W. Macyk, A. Drzewiecka-Matuszek, M. Brindell, G. Stochel, Bioinorganic photochemistry: frontiers and mechanisms, Chem. Rev. 105 (2005) 2647-2694;
13. (b) R.K. Pandey, S. Constantine, T. Tsuchida, G. Zheng, C.J. Medforth, M. Aoudia, A. N. Kozyrev, M.A.J. Rodgers, H. Kato, K.M. Smith, T.J. Dougherty, Synthesis, photophysical properties, in vivo photosensitizing efficacy, and human serum albumin binding properties of some novel bacteriochlorins, J. Med. Chem. 40 (1997) 2770-2779.
14. T. Tsuchida, G. Zheng, R.K. Pandey, W.R. Potter, D.A. Bellnier, B.W. Henderson, H. Kato, T.J. Dougherty, Correlation between site II-specific human serum albumin (HSA) binding affinity and murine in vivo photosensitizing efficacy of some photofrin components, Photochem. Photobiol. 66 (1997) 224-228.
15. E.D. Sternberg, D. Dolphin, C. Brückner, Porphyrin-based photosensitizers for use in photodynamic therapy, Tetrahedron 54 (1998) 4151-4202.
16. B.W. Henderson, T.J. Dougherty, How does photodynamic therapy work? Photochem. Photobiol. 55 (1992) 145-157.
17. O. Rinco, J. Brenton, A. Douglas, A. Maxwell, M. Henderson, K. Indrelie, J. Wessels, J. Widin, The effect of porphyrin structure on binding to human serum albumin by fluorescence spectroscopy, J. Photochem. Photobiol. A: Chem. 208 (2009) 91-96.
18. S. Yano, S. Hirohara, M. Obata, Y. Hagiya, S. Ogura, A. Ikeda, H. Kataoka, M. Tanaka, T. Joh, Current states and future views in photodynamic therapy, J. Photochem. Photobiol. C: Photochem. Rev. 12 (2011) 46-67.
19. E. Delaey, F. van Laar, D. De Vos, A. Kamuhabwa, P. Jaobs, P.J. De Witte, A comparative study of the photosensitizing characteristics of some cyanine dyes, Photochem. Photobiol. B: Biol. 55 (2000) 27-36.
20. D. Wöhrle, M. Shopova, S. Muller, A.D. Milev, V.N. Mantareva, K.K. Krastev, Effect of delivery system on the pharmacokinetic and phototherapeutic properties of bis(methyloxyethyleneoxy) silicon-phthalocyanine in tumor-bearing mice, J. Photochem. Photobiol. B: Biol. 50 (1999) 124-128.
21. A. Gorman, J. Killoran, C. O'shea, T. Kenna, W.M. Gallagher, D.F. O'shea, In vitro demonstration of the heavy-atom effect for photodynamic therapy, J. Am. Chem. Soc. 126 (2004) 10619-10631.
22. K. Liang, K.Y. Law, Synthesis, characterization, photophysics, and photosensitization studies of squaraine-bipyridinium diads, J. Phys. Chem. B 101 (1997) 540-546.
23. (a) J. Park, C. Barolo, F. Sauvage, N. Barbero, C. Benzi, P. Quagliotto, S. Coluccia, D. Di Censo, M. Grätzel, MdK. Nazeeruddin, G. Viscardi, Symmetric vs. asymmetric squaraines as photosensitisers in mesoscopic injection solar cells: a structure-property relationship study, Chem. Commun. 48 (2012) 2782-2784;
24. (b) C. Magistris, S. Martiniani, N. Barbero, J. Park, C. Benzi, A. Anderson, C. Law, C. Barolo, B. O'Regan, Near-infrared absorbing squaraine dye with extended π conjugation for dye-sensitized solar cells, Renew. Energy 60 (2013) 672-678.
25. (a) G.J. Ashwell, J. Ewington, K. Moczko, Orientation-induced molecular rectification and nonlinear optical properties of a squaraine derivative, J. Mater. Chem. 15 (2005) 1154-1159;
26. (b) L. Beverina, P. Salice, Squaraine compounds: tailored design and synthesis towards a variety of material science applications, Eur. J. Org. Chem. (2010) 1207-1225.
27. (a) V.S. Jisha, K.T. Arun, M. Hariharan, D. Ramaiah, Site-selective binding and dual mode recognition of serum albumin by a squaraine dye, J. Am. Chem. Soc. 128 (2006) 6024-6025;
28. (b) J.J. McEwen, K.J. Wallace, Squaraine dyes in molecular recognition and self-assembly, Chem. Commun. (2009) 6339-6351.
29. R.R. Avirah, D.T. Jayaram, A. Adarsh, D. Ramaiah, Squaraine dyes in PDT: from basic design to in vivo demonstration, Org. Biomol. Chem. 10 (2012) 911-920.
30. A. Treibs, K. Jacob, Cyclotrimethine dyes derived from squaric acid angew, Chem. Int. Ed. Engl. 4 (1965) 694.
31. J.D. Park, S. Cohen, J.R. Lacher, Hydrolysis reactions of halogenated cyclobutene ethers: synthesis of diketocyclobutenediol, J. Am. Chem. Soc. 84 (1962) 2919-2922.
32. (a) L. Sulkowski, A. Sulkowska, J. Rownicka, B. Bojko, A. Sieron, D. Pentak, W.W. Sulkowski, The effect of serum albumin on binding of protoporphyrin IX to phospholipid membrane, Mol. Cryst. Liq. Cryst. 448 (2006) 73-81;
33. (b) V.S. Jisha, K.T. Arun, M. Hariharan, D. Ramaiah, Site selective interactions: squarenedyes - serum albumin complexes with enhanced flourescence and triplet yields, J. Phys. Chem. B 114 (2010) 5912-5919.
34. C.-Q. Xiao, F.-L. Jiang, B. Zhou, R. Lia, Y. Liu, Interaction between a cationic porphyrin and bovine serum albumin studied by surface plasmon resonance, fluorescence spectroscopy, and cyclic voltammetry, Photochem. Photobiol. Sci. 10 (2011) 1110-1117.
35. I.E. Borissevitch, T.T. Tominaga, H. Imasato, M. Tabak, Fluorescence and optical absorption study of interaction of two water soluble porphyrins with bovine serum albumin. The role of albumin and porphyrin aggregation, J. Lumin. 69 (1996) 65-76.
36. (a) S. Das, T.L. Thanulingam, K.G. Thomas, P.V. Kamat, M.V. George, Photochemistry of squaraine dyes. 5. Aggregation of bis(2,4-dihydroxyphenyl) squaraine and bis(2,4,6-trihydroxyphenyl)squaraine and their photodissociation in acetonitrile solutions, J. Phys. Chem. 97 (1993) 13620-13624;
37. (b) L. Monsù Scolaro, M. Castriciano, A. Romeo, S. Patanè, E. Cefalì, M. Allegrini, Aggregation behavior of protoporphyrin IX in aqueous solutions: clear evidence of vesicle formation, J. Phys. Chem. B 106 (2002) 2453-2459.
38. N. Barbero, L. Napione, S. Visentin, M. Alvaro, A. Veglio, F. Bussolino, G. Viscardi, A transient kinetic study between signaling proteins: the case of the MEK-ERK interaction, Chem. Sci. 2 (2011) 1804-1809.
39. J. Wilting, J.M.H. Kremer, A.P. Ijzerman, S.G. Schulman, The kinetics of the binding of warfarin to human serum albumin as studied by stopped-flow spectrophotometry, Biochim. Biophys. Acta 706 (1982) 96-104.
40. I. Fitos, J. Visy, J. Kardos, Stereoselective kinetics of warfarin binding to human serum albumin: effect of an allosteric interaction, Chirality 14 (2002) 442-448.
41. R.A. Copeland, D.L. Pompliano, T.D. Meek, Drug-target residence time and its implications for lead optimization, Nat. Rev. Drug Discov. 5 (2006) 730-739.